An increase of oxidative stress markers and the alteration of the antioxidant enzymatic system are associated with spleen damage caused by methimazole-induced hypothyroidism
Authors:
- Vanessa Blas-ValdiviaVBVanessa Blas-Valdivia
- Margarita Franco-ColinMFMargarita Franco-Colin
- Marisol Pineda-ReynosoMPMarisol Pineda-Reynoso
- Edgar Cano-EuropaEdgar Cano-Europa
- 12 February 2011
- journal article
- research article
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 34 (2) , 180-188
Abstract
Methimazole is the most widely used antithyroid drug in Europe and North America, but it causes several undesirable side effects, such as hematological dysfunctions and immunosuppression. Our aim in this work was to compare, over a time course, markers of oxidative stress, the redox environment, the antioxidant enzymatic system, and the glutathione cycle in the spleen of rats with methimazole- or thyroidectomy-caused hypothyroidism. We used 70-male Wistar rats divided into four groups: 1) euthyroid; 2) sham thyroidectomy; 3) thyroidectomy-caused hypothyroidism, with parathyroid reimplant; and 4) methimazole-caused hypothyroidism. Five rats of the euthyroid- and methimazole-caused hypothyroidism groups were killed at the end of weeks 1, 2, 3, and 4 after treatment, and 5 rats of the sham thyroidectomy and thyroidectomy-caused hypothyroidism groups were killed at the end of weeks 2, 4, and 8 after the surgical procedure. Each spleen was excised and stored at −70°C until oxidative stress, REDOX environment, and the antioxidant enzymatic-system markers were tested. The histological study showed that only methimazole-induced hypothyroidism caused cell damage. This damage was associated with an increase of oxidative-stress markers that were not compensated for by the antioxidant system. The increase of the glutathione-cycle enzymes was insufficient to prevent oxidative-stress markers. Methimazole causes oxidative stress and cell damage in the spleen, whereas hypothyroidism per se does not cause cell damage in this organ. Therefore, it is necessary to develop new antithyroid drugs without causing oxidative stress and cellular damage.Keywords
This publication has 31 references indexed in Scilit:
- Lidocaine affects the redox environment and the antioxidant enzymatic system causing oxidative stress in the hippocampus and amygdala of adult ratsLife Sciences, 2008
- Induced hypothyroidism accelerates the regression of liver fibrosis in ratsJournal of Gastroenterology and Hepatology, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Reduction in oxidative stress and cell death explains hypothyroidism induced neuroprotection subsequent to ischemia/reperfusion insultExperimental Neurology, 2006
- Thyroid hormone stimulates γ‐glutamyl transpeptidase in the developing rat cerebra and in astroglial culturesJournal of Neuroscience Research, 2005
- Selenium and endocrine systemsJournal of Endocrinology, 2005
- Necrotizing Glomerulonephritis and Pulmonary Hemorrhage Associated with Carbimazole TherapyThyroid®, 2005
- Antioxidant Enzymes and ApoptosisDrug Metabolism Reviews, 2004
- Hypothyroidism renders liver mitochondria resistant to the opening of membrane permeability transition poreBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1998
- Inhibition of Experimentally Induced Cirrhosis in Rats by HypothyroidismHepatology, 1996